tiprankstipranks
Percheron Therapeutics (PERCF)
OTHER OTC:PERCF
Holding PERCF?
Track your performance easily

Percheron Therapeutics (PERCF) Technical Analysis

12 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
2Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Percheron Therapeutics’s (PERCF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Percheron Therapeutics is a Sell.
Percheron Therapeutics’s (PERCF) 20-Day exponential moving average is 0.04, while Percheron Therapeutics’s (PERCF) share price is <$0.1, making it a Sell.
Percheron Therapeutics’s (PERCF) 50-Day exponential moving average is 0.04, while Percheron Therapeutics’s (PERCF) share price is <$0.1, making it a Sell.

Percheron Therapeutics (PERCF) Pivot Points

Dec 22, 2024, 08:19 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Fibonacci
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Percheron Therapeutics (PERCF) Moving Averages

Dec 22, 2024, 08:19 AM
Period
Simple
Exponential
MA5
0.04Buy
0.04Sell
MA10
0.04Buy
0.04Sell
MA20
0.04Sell
0.04Sell
MA50
0.05Sell
0.04Sell
MA100
0.03Buy
0.03Buy
MA200
0.02Buy
0.03Buy
Percheron Therapeutics’s (PERCF) 10-Day exponential moving average is 0.04, while Percheron Therapeutics’s (PERCF) share price is <$0.1, making it a Sell.
Percheron Therapeutics’s (PERCF) 100-Day exponential moving average is 0.03, while Percheron Therapeutics’s (PERCF) share price is <$0.1, making it a Buy.
Percheron Therapeutics’s (PERCF) stock price is <$0.1 and Percheron Therapeutics’s (PERCF) 50-day simple moving average is 0.05, creating a Sell signal.
Percheron Therapeutics’s (PERCF) stock price is <$0.1 and Percheron Therapeutics’s (PERCF) 100-day simple moving average is 0.03, creating a Buy signal.
Percheron Therapeutics’s (PERCF) stock price is <$0.1 and Percheron Therapeutics’s (PERCF) 200-day simple moving average is 0.02, creating a Buy signal.

Percheron Therapeutics (PERCF) Technical Indicators

Dec 22, 2024, 08:19 AM
Name
Value
Implied Action
RSI (14)
32.65
Neutral
STOCH (9,6)
0.00
-
STOCHRSI (14)
<0.01
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
35.36
Neutral
CCI (14)
0.00
-
ATR (14)
<0.01
-
Ultimate Oscillator
-0.46
Sell
ROC
0.00
-
Bull/Bear Power (13)
<0.01
Buy
Percheron Therapeutics’s (PERCF) Relative Strength Index (RSI) is 32.65, creating a Neutral signal.
Percheron Therapeutics’s (PERCF) Trend Strength Indicator (ADX) is 35.36, creating a Neutral signal.

FAQ

Is PERCF a Buy, Hold, or Sell?
Based on PERCF’s technical indicators, PERCF is a Hold.
    What is PERCF’s RSI (14)?
    PERCF’s RSI (14) is 32.65, which suggests PERCF is a Neutral.
      What is PERCF’s MACD?
      PERCF’s MACD is >-0.01, which suggests PERCF is a Sell.
        What is PERCF’s 5-day moving average?
        PERCF’s 5-day moving average is 0.04, which suggests PERCF is a Buy.
          What is PERCF’s 20-day moving average?
          PERCF 20-day moving average is 0.04, which suggests PERCF is a Sell.
            What is PERCF’s 50-day moving average?
            PERCF’s 50-day moving average is 0.05, which suggests PERCF is a Sell.
              What is PERCF’s 200-day moving average?
              PERCF’s 200-day moving average is 0.02, which suggests PERCF is a Buy.
                What is PERCF’s Williams % R (14)?
                Currently, no data Available
                What is PERCF’s CCI (14)?
                Currently, no data Available
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis